Curis
CRIS
#10345
Rank
NZ$33.01 M
Marketcap
NZ$0.85
Share price
1.19%
Change (1 day)
-75.30%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.22. In 2024 the company made an earnings per share (EPS) of NZ-$11.91 an increase over its 2023 EPS that were of NZ-$15.29.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-46.4%
2024NZ-$11.91-22.15%
2023NZ-$15.29-26.17%
2022NZ-$20.7122.3%
2021NZ-$16.94-25.37%
2020NZ-$22.70-30.93%
2019NZ-$32.86-2.02%
2018NZ-$33.54
2016NZ-$76.22-10%
2015NZ-$84.68138.1%
2014NZ-$35.5740%
2013NZ-$25.41-25%
2012NZ-$33.8766.67%
2011NZ-$20.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.22-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.03-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.30-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.59 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.04 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.39-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA